Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes

Respiratory Research

Table 3 Factors associated with transition from former type 2-high or -intermediate groups to the current type 2-low group

	Odds (95% confidence interval)	p-value
Age, year	1.08 (0.99–1.16)	0.054
Sex, female	1.21 (0.22–6.55)	0.82
Period between diagnosis of asthma and bronchiectasis/bronchiolitis, year	0.89 (0.81–0.98)	0.02
Long-term OCS use^*, yes	10.7 (1.45–79.3)	0.02
Exhaled nitric oxide in the past, ppb	0.96 (0.93–0.99)	0.04
Blood eosinophil count in the past, /μL	0.999 (0.997–1.001)	0.32
N = 53	R²	0.39

OCS oral corticosteroid. *Long-term OCS use was defined as regular current or past OCS use

ISSN: 1465-993X